1	Costimulation	costimulation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	peripheral	peripheral	_	_	_	_	_	_	_
4	blood	blood	_	_	_	_	_	_	_
5	T	t	_	_	_	_	_	_	_
6	cell	cell	_	_	_	_	_	_	_
7	activation	activation	_	_	_	_	_	_	_
8	by	by	_	_	_	_	_	_	_
9	human	human	_	_	_	_	_	_	_
10	endothelial	endothelial	_	_	_	_	_	_	_
11	cells	cell	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	Enhanced	enhance	_	_	_	_	_	_	_
2	IL-2	il-2	_	_	_	_	_	_	_
3	transcription	transcription	_	_	_	_	_	_	_
4	correlates	correlate	_	_	_	_	_	_	_
5	with	with	_	_	_	_	_	_	_
6	increased	increase	_	_	_	_	_	_	_
7	c-fos	c-fos	_	_	_	_	_	_	_
8	synthesis	synthesis	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	increased	increase	_	_	_	_	_	_	_
11	Fos	fos	_	_	_	_	_	_	_
12	content	content	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	AP-1	ap-1	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Endothelial	endothelial	_	_	_	_	_	_	_
2	cells	cell	_	_	_	_	_	_	_
3	(	(	_	_	_	_	_	_	_
4	EC	EC	_	_	_	_	_	_	_
5	)	)	_	_	_	_	_	_	_
6	act	act	_	_	_	_	_	_	_
7	as	as	_	_	_	_	_	_	_
8	APC	APC	_	_	_	_	_	_	_
9	for	for	_	_	_	_	_	_	_
10	resting	rest	_	_	_	_	_	_	_
11	PBL	pbl	_	_	_	_	_	_	_
12	in	in	_	_	_	_	_	_	_
13	vitro	vitro	_	_	_	_	_	_	_
14	,	,	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	may	may	_	_	_	_	_	_	_
17	have	have	_	_	_	_	_	_	_
18	important	important	_	_	_	_	_	_	_
19	roles	role	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	vivo	vivo	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	pathogenesis	pathogenesis	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	allograft	allograft	_	_	_	_	_	_	_
27	rejection	rejection	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	delayed	delay	_	_	_	_	_	_	_
30	hypersensitivity	hypersensitivity	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	previously	previously	_	_	_	_	_	_	_
3	reported	report	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	human	human	_	_	_	_	_	_	_
6	umbilical	umbilical	_	_	_	_	_	_	_
7	vein	vein	_	_	_	_	_	_	_
8	EC	EC	_	_	_	_	_	_	_
9	provide	provide	_	_	_	_	_	_	_
10	costimulatory	costimulatory	_	_	_	_	_	_	_
11	signals	signal	_	_	_	_	_	_	_
12	to	to	_	_	_	_	_	_	_
13	PHA-stimulated	pha-stimulated	_	_	_	_	_	_	_
14	PBL	pbl	_	_	_	_	_	_	_
15	via	via	_	_	_	_	_	_	_
16	CD2:lymphocyte	CD2:lymphocyte	_	_	_	_	_	_	_
17	function-associated	function-associated	_	_	_	_	_	_	_
18	Ag-3	ag-3	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	an	an	_	_	_	_	_	_	_
21	unidentified	unidentified	_	_	_	_	_	_	_
22	ligand	ligand	_	_	_	_	_	_	_
23	pair	pair	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	resulting	result	_	_	_	_	_	_	_
26	in	in	_	_	_	_	_	_	_
27	a	a	_	_	_	_	_	_	_
28	three-	three-	_	_	_	_	_	_	_
29	to	to	_	_	_	_	_	_	_
30	eight-fold	eight-fold	_	_	_	_	_	_	_
31	enhancement	enhancement	_	_	_	_	_	_	_
32	of	of	_	_	_	_	_	_	_
33	IL-2	il-2	_	_	_	_	_	_	_
34	production	production	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	physiologic	physiologic	_	_	_	_	_	_	_
3	relevance	relevance	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	this	this	_	_	_	_	_	_	_
6	increase	increase	_	_	_	_	_	_	_
7	was	be	_	_	_	_	_	_	_
8	demonstrated	demonstrate	_	_	_	_	_	_	_
9	by	by	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	proliferative	proliferative	_	_	_	_	_	_	_
12	advantage	advantage	_	_	_	_	_	_	_
13	provided	provide	_	_	_	_	_	_	_
14	by	by	_	_	_	_	_	_	_
15	EC	EC	_	_	_	_	_	_	_
16	to	to	_	_	_	_	_	_	_
17	PBL	pbl	_	_	_	_	_	_	_
18	suboptimally	suboptimally	_	_	_	_	_	_	_
19	stimulated	stimulate	_	_	_	_	_	_	_
20	with	with	_	_	_	_	_	_	_
21	mAb	mab	_	_	_	_	_	_	_
22	OKT3	okt3	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	now	now	_	_	_	_	_	_	_
3	report	report	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	EC	EC	_	_	_	_	_	_	_
6	costimulation	costimulation	_	_	_	_	_	_	_
7	causes	cause	_	_	_	_	_	_	_
8	increased	increase	_	_	_	_	_	_	_
9	levels	level	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	IL-2	il-2	_	_	_	_	_	_	_
12	mRNA	mrna	_	_	_	_	_	_	_
13	as	as	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	result	result	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	increased	increase	_	_	_	_	_	_	_
18	IL-2	il-2	_	_	_	_	_	_	_
19	transcription	transcription	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	PBL	PBL	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	therefore	therefore	_	_	_	_	_	_	_
3	examined	examine	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	effects	effect	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	EC	EC	_	_	_	_	_	_	_
8	on	on	_	_	_	_	_	_	_
9	T	t	_	_	_	_	_	_	_
10	cell	cell	_	_	_	_	_	_	_
11	nuclear	nuclear	_	_	_	_	_	_	_
12	factors	factor	_	_	_	_	_	_	_
13	known	know	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	regulate	regulate	_	_	_	_	_	_	_
16	IL-2	il-2	_	_	_	_	_	_	_
17	transcription	transcription	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	including	include	_	_	_	_	_	_	_
20	c-jun	c-jun	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	c-fos-two	c-fos-two	_	_	_	_	_	_	_
23	components	component	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	transcription	transcription	_	_	_	_	_	_	_
27	factor	factor	_	_	_	_	_	_	_
28	AP-1	ap-1	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	NFAT	NFAT	_	_	_	_	_	_	_
31	,	,	_	_	_	_	_	_	_
32	and	and	_	_	_	_	_	_	_
33	others	other	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	PBL	PBL	_	_	_	_	_	_	_
2	constitutively	constitutively	_	_	_	_	_	_	_
3	express	express	_	_	_	_	_	_	_
4	c-jun	c-jun	_	_	_	_	_	_	_
5	transcripts	transcript	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	level	level	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	c-jun	c-jun	_	_	_	_	_	_	_
12	mRNA	mRNA	_	_	_	_	_	_	_
13	is	be	_	_	_	_	_	_	_
14	not	not	_	_	_	_	_	_	_
15	altered	alter	_	_	_	_	_	_	_
16	by	by	_	_	_	_	_	_	_
17	PHA	PHA	_	_	_	_	_	_	_
18	activation	activation	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	absence	absence	_	_	_	_	_	_	_
22	or	or	_	_	_	_	_	_	_
23	presence	presence	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	EC	EC	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	c-fos	c-fos	_	_	_	_	_	_	_
5	mRNA	mRNA	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	absent	absent	_	_	_	_	_	_	_
8	from	from	_	_	_	_	_	_	_
9	resting	rest	_	_	_	_	_	_	_
10	T	t	_	_	_	_	_	_	_
11	cells	cell	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	is	be	_	_	_	_	_	_	_
14	induced	induce	_	_	_	_	_	_	_
15	on	on	_	_	_	_	_	_	_
16	PHA	PHA	_	_	_	_	_	_	_
17	activation	activation	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	EC	EC	_	_	_	_	_	_	_
2	alone	alone	_	_	_	_	_	_	_
3	do	do	_	_	_	_	_	_	_
4	not	not	_	_	_	_	_	_	_
5	induce	induce	_	_	_	_	_	_	_
6	c-fos	c-fos	_	_	_	_	_	_	_
7	mRNA	mrna	_	_	_	_	_	_	_
8	but	but	_	_	_	_	_	_	_
9	augment	augment	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	level	level	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	c-fos	c-fos	_	_	_	_	_	_	_
14	mRNA	mrna	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	PHA-activated	pha-activated	_	_	_	_	_	_	_
17	T	t	_	_	_	_	_	_	_
18	cells	cell	_	_	_	_	_	_	_
19	by	by	_	_	_	_	_	_	_
20	3-	3-	_	_	_	_	_	_	_
21	to	to	_	_	_	_	_	_	_
22	10-fold	10-fold	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	effect	effect	_	_	_	_	_	_	_
3	is	be	_	_	_	_	_	_	_
4	largely	largely	_	_	_	_	_	_	_
5	independent	independent	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	CD2:lymphocyte	CD2:lymphocyte	_	_	_	_	_	_	_
9	function-associated	function-associated	_	_	_	_	_	_	_
10	Ag-3	ag-3	_	_	_	_	_	_	_
11	pathway	pathway	_	_	_	_	_	_	_
12	.	.	_	_	_	_	_	_	_

1	Gel-shift	gel-shift	_	_	_	_	_	_	_
2	analysis	analysis	_	_	_	_	_	_	_
3	reveals	reveal	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	constitutive	constitutive	_	_	_	_	_	_	_
6	presence	presence	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	nuclear	nuclear	_	_	_	_	_	_	_
9	factors	factor	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	resting	rest	_	_	_	_	_	_	_
12	PBL	pbl	_	_	_	_	_	_	_
13	that	that	_	_	_	_	_	_	_
14	bind	bind	_	_	_	_	_	_	_
15	to	to	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	proximal	proximal	_	_	_	_	_	_	_
18	AP-1	ap-1	_	_	_	_	_	_	_
19	site	site	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	IL-2	il-2	_	_	_	_	_	_	_
23	promoter	promoter	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	that	that	_	_	_	_	_	_	_
26	contain	contain	_	_	_	_	_	_	_
27	immunoreactive	immunoreactive	_	_	_	_	_	_	_
28	c-Jun	c-jun	_	_	_	_	_	_	_
29	but	but	_	_	_	_	_	_	_
30	not	not	_	_	_	_	_	_	_
31	c-Fos	c-fos	_	_	_	_	_	_	_
32	protein	protein	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	AP-1	ap-1	_	_	_	_	_	_	_
5	from	from	_	_	_	_	_	_	_
6	PHA-activated	pha-activated	_	_	_	_	_	_	_
7	cells	cell	_	_	_	_	_	_	_
8	contains	contain	_	_	_	_	_	_	_
9	c-Jun	c-jun	_	_	_	_	_	_	_
10	and	and	_	_	_	_	_	_	_
11	low	low	_	_	_	_	_	_	_
12	levels	level	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	c-Fos	c-fos	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Strikingly	strikingly	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	costimulation	costimulation	_	_	_	_	_	_	_
4	with	with	_	_	_	_	_	_	_
5	EC	EC	_	_	_	_	_	_	_
6	results	result	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	dramatic	dramatic	_	_	_	_	_	_	_
10	increase	increase	_	_	_	_	_	_	_
11	(	(	_	_	_	_	_	_	_
12	up	up	_	_	_	_	_	_	_
13	to	to	_	_	_	_	_	_	_
14	15-fold	15-fold	_	_	_	_	_	_	_
15	)	)	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	c-Fos	c-fos	_	_	_	_	_	_	_
19	content	content	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	AP-1	ap-1	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Levels	level	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	other	other	_	_	_	_	_	_	_
4	nuclear	nuclear	_	_	_	_	_	_	_
5	factors	factor	_	_	_	_	_	_	_
6	involved	involve	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	IL-2	il-2	_	_	_	_	_	_	_
9	regulation	regulation	_	_	_	_	_	_	_
10	were	be	_	_	_	_	_	_	_
11	not	not	_	_	_	_	_	_	_
12	altered	alter	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	EC	EC	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	although	although	_	_	_	_	_	_	_
17	NFAT-DNA	NFAT-DNA	_	_	_	_	_	_	_
18	complexes	complex	_	_	_	_	_	_	_
19	migrated	migrate	_	_	_	_	_	_	_
20	at	at	_	_	_	_	_	_	_
21	a	a	_	_	_	_	_	_	_
22	slightly	slightly	_	_	_	_	_	_	_
23	different	different	_	_	_	_	_	_	_
24	mobility	mobility	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	summary	summary	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	our	our	_	_	_	_	_	_	_
5	data	datum	_	_	_	_	_	_	_
6	suggest	suggest	_	_	_	_	_	_	_
7	that	that	_	_	_	_	_	_	_
8	changes	change	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	composition	composition	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	transcription	transcription	_	_	_	_	_	_	_
14	factor	factor	_	_	_	_	_	_	_
15	AP-1	ap-1	_	_	_	_	_	_	_
16	is	be	_	_	_	_	_	_	_
17	a	a	_	_	_	_	_	_	_
18	key	key	_	_	_	_	_	_	_
19	molecular	molecular	_	_	_	_	_	_	_
20	mechanism	mechanism	_	_	_	_	_	_	_
21	for	for	_	_	_	_	_	_	_
22	increasing	increase	_	_	_	_	_	_	_
23	IL-2	il-2	_	_	_	_	_	_	_
24	transcription	transcription	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	may	may	_	_	_	_	_	_	_
27	underlie	underlie	_	_	_	_	_	_	_
28	the	the	_	_	_	_	_	_	_
29	phenomenon	phenomenon	_	_	_	_	_	_	_
30	of	of	_	_	_	_	_	_	_
31	costimulation	costimulation	_	_	_	_	_	_	_
32	by	by	_	_	_	_	_	_	_
33	EC	EC	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

